Cost-effectiveness of proton beam therapy for intraocular melanoma.
about
Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer.A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.Point/Counterpoint. Particle therapy is ideal for the treatment of ocular melanomas.The evolution of proton beam therapy: Current and future status.
P2860
Cost-effectiveness of proton beam therapy for intraocular melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-effectiveness of proton beam therapy for intraocular melanoma.
@ast
Cost-effectiveness of proton beam therapy for intraocular melanoma.
@en
type
label
Cost-effectiveness of proton beam therapy for intraocular melanoma.
@ast
Cost-effectiveness of proton beam therapy for intraocular melanoma.
@en
prefLabel
Cost-effectiveness of proton beam therapy for intraocular melanoma.
@ast
Cost-effectiveness of proton beam therapy for intraocular melanoma.
@en
P2093
P2860
P1433
P1476
Cost-effectiveness of proton beam therapy for intraocular melanoma.
@en
P2093
Bijan J Borah
Jose S Pulido
Nilay D Shah
Robert L Foote
P2860
P304
P356
10.1371/JOURNAL.PONE.0127814
P407
P577
2015-05-18T00:00:00Z